Biomea Fusion Inc (BMEA)
6.38
+0.10
(+1.59%)
USD |
NASDAQ |
Nov 21, 16:00
6.39
+0.01
(+0.16%)
After-Hours: 20:00
Biomea Fusion Shareholders Equity (Quarterly): 75.97M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 75.97M |
| June 30, 2024 | 103.94M |
| March 31, 2024 | 135.31M |
| December 31, 2023 | 169.24M |
| September 30, 2023 | 199.61M |
| June 30, 2023 | 224.30M |
| March 31, 2023 | 83.13M |
| December 31, 2022 | 108.54M |
| Date | Value |
|---|---|
| September 30, 2022 | 130.64M |
| June 30, 2022 | 150.39M |
| March 31, 2022 | 164.76M |
| December 31, 2021 | 178.78M |
| September 30, 2021 | 191.33M |
| June 30, 2021 | 202.02M |
| March 31, 2021 | 0.221M |
| December 31, 2020 | 5.169M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.221M
Minimum
Mar 2021
224.30M
Maximum
Jun 2023
132.71M
Average
142.85M
Median
Shareholders Equity (Quarterly) Benchmarks
| Clearside Biomedical Inc | -34.79M |
| Crinetics Pharmaceuticals Inc | 832.98M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 110.42M |
| Total Liabilities (Quarterly) | 34.45M |